Harari-Steinfeld Rona, Gefen Maytal, Simerzin Alina, Zorde-Khvalevsky Elina, Rivkin Mila, Ella Ezra, Friehmann Tomer, Gerlic Mordechay, Zucman-Rossi Jessica, Caruso Stefano, Leveille Mélissa, Estall Jennifer L, Goldenberg Daniel S, Giladi Hilla, Galun Eithan, Bromberg Zohar
The Goldyne Savad Institute of Gene and Cell Therapy, Hadassah Hebrew University Medical Center, Ein Karem, P.O.B. 12000, Jerusalem 9112001, Israel.
Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel.
Cancers (Basel). 2021 Jan 22;13(3):411. doi: 10.3390/cancers13030411.
The -derived microRNA-675 (miR-675) has been implicated as both tumor promoter and tumor suppressor and also plays a role in liver inflammation. We found that miR-675 promotes cell death in human hepatocellular carcinoma (HCC) cell lines. We show that Fas-associated protein with death domain (FADD), a mediator of apoptotic cell death signaling, is downregulated by miR-675 and a negative correlation exists between miR-675 and FADD expression in mouse models of HCC ( = 0.014) as well as in human samples ( = 0.017). We demonstrate in a mouse model of liver inflammation that overexpression of miR-675 promotes necroptosis, which can be inhibited by the necroptosis-specific inhibitor Nec-1/Nec-1s. miR-675 induces the level of both p-MLKL (Mixed Lineage Kinase Domain-Like Pseudokinase) and RIP3 (receptor-interacting protein 3), which are key signaling molecules in necroptosis, and enhances MLKL binding to RIP3. miR-675 also inhibits the levels of cleaved caspases 8 and 3, suggesting that miR-675 induces a shift from apoptosis to a necroptotic cellular pathway. In conclusion, downregulation of FADD by miR-675 promotes liver necroptosis in response to inflammatory signals. We propose that this regulation cascade can stimulate and enhance the inflammatory response in the liver, making miR-675 an important regulator in liver inflammation and potentially also in HCC.
源自 的微小RNA-675(miR-675)已被认为既是肿瘤促进因子又是肿瘤抑制因子,并且在肝脏炎症中也发挥作用。我们发现miR-675可促进人肝癌(HCC)细胞系中的细胞死亡。我们表明,凋亡细胞死亡信号传导的介质死亡结构域相关蛋白(FADD)被miR-675下调,并且在HCC小鼠模型(= 0.014)以及人类样本(= 0.017)中,miR-675与FADD表达之间存在负相关。我们在肝脏炎症小鼠模型中证明,miR-675的过表达促进坏死性凋亡,这可被坏死性凋亡特异性抑制剂Nec-1/Nec-1s抑制。miR-675诱导坏死性凋亡的关键信号分子p-MLKL(混合谱系激酶结构域样假激酶)和RIP3(受体相互作用蛋白3)的水平升高,并增强MLKL与RIP3的结合。miR-675还抑制裂解的半胱天冬酶8和3的水平,表明miR-675诱导从凋亡向坏死性细胞途径的转变。总之,miR-675对FADD的下调促进了肝脏对炎症信号的坏死性凋亡。我们提出,这种调节级联反应可刺激和增强肝脏中的炎症反应,使miR-675成为肝脏炎症以及潜在的HCC中的重要调节因子。 (注:原文中“ -derived”处有缺失内容)